Emerging Treatment Approaches for Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, manifesting as a characteristic movement disorder with a number of additional non-motor features. The pathological hallmark of PD is the presence of intra-neuronal aggregates of α-synuclein (Lewy bodies). The movement diso...
Main Authors: | Thomas B. Stoker, Kelli M. Torsney, Roger A. Barker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00693/full |
Similar Items
-
Neural grafting for Parkinson's disease: challenges and prospects
by: Thomas B Stoker, et al.
Published: (2017-01-01) -
Recent developments in the treatment of Parkinson's Disease [version 1; peer review: 2 approved]
by: Thomas B Stoker, et al.
Published: (2020-07-01) -
Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
by: Abbie T. Rodger, et al.
Published: (2023-07-01) -
The role of Ca2+ signaling in Parkinson's disease
by: Sofia V. Zaichick, et al.
Published: (2017-05-01) -
Study of abnormal microflora in progression and treatment of Parkinson's disease
by: Yue Xinyi, Zhou Qingbo
Published: (2023-05-01)